MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
December 2, 2004
W.D. Crotty
Nothing to Pall Over Filtration, separation, and purification giant Pall reported an 11% increase in revenue for the first fiscal quarter. While Pall is the global leader in its markets, there is mounting competition from industrial giants. mark for My Articles similar articles
The Motley Fool
December 14, 2011
Neha Chamaria
Can Pall Stand Tall After an Impressive Quarter? Emerging markets play a positive role. mark for My Articles similar articles
The Motley Fool
November 3, 2011
Keki Fatakia
Should You Be Worried About Danaher? Danaher reports 46% higher revenues, but why are profits down? mark for My Articles similar articles
Chemistry World
May 10, 2006
Katharine Sanderson
Leading Lab Suppliers Merge Analytical instrument firm Thermo Electron and chemical manufacturer Fisher Scientific announced a merger, aiming to become the leading provider of laboratory products and services in the health sciences industry. mark for My Articles similar articles
The Motley Fool
June 2, 2004
Bill Mann
A Little Cloudy at Pall Purification and filtration giant Pall comes in a little light. mark for My Articles similar articles
The Motley Fool
December 15, 2005
Tim Hanson
The Best $17 Billion Company You Don't Know Contrary to popular belief, large caps can fly under the radar. Danaher is simply a conglomerate of boring companies that the world can't do without. Investors, take note. mark for My Articles similar articles
Chemistry World
July 8, 2015
Phillip Broadwith
Thermo Fisher to buy Alfa Aesar chemical supplies The acquisition complements its existing Fisher Scientific chemicals supply segment, and will be integrated with its laboratory products and services portfolio. mark for My Articles similar articles
The Motley Fool
June 2, 2005
Stephen D. Simpson
Pall's Play for Purity This filtration company faces near-term challenges, but its markets are poised for growth. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 14, 2006
Anders Bylund
Margins Are Your Pals, Pall How will the filtration company revive flagging growth and thinning margins? Investors, take note. mark for My Articles similar articles
The Motley Fool
February 7, 2008
Brian Orelli
A Lab Match Made in Heaven The case of Thermo Electron and Fisher Scientific shows why mergers work. mark for My Articles similar articles
The Motley Fool
December 15, 2008
Chris Jones
Pall Falters, but Doesn't Fall Filter manufacturer Pall is a solid company with management that is prepared to guide it through the oncoming economic onslaught. mark for My Articles similar articles
The Motley Fool
September 13, 2005
Stephen D. Simpson
A Shadow on Pall While the water filtration company Pall is in some interesting and attractive business segments, I can't see any compelling reason to pay such a high price for the stock. mark for My Articles similar articles
Chemistry World
January 8, 2014
Phillip Broadwith
Thermo Fisher to sell three analytical divisions to GE Healthcare GE will take over Thermo's cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013. mark for My Articles similar articles
The Motley Fool
May 8, 2006
Stephen D. Simpson
Fisher Scientific Reels In a Deal A fair price and impressive market leverage give this merger between Fisher Scientific and Thermo Electron a better-than-average chance. Shareholders, take note. mark for My Articles similar articles
The Motley Fool
December 7, 2005
Stephen D. Simpson
Why Pay for Pall? Filtration is still a good business, but this firm's modest performance doesn't impress shareholders. mark for My Articles similar articles
The Motley Fool
May 2, 2006
Stephen D. Simpson
Still Fishing for Value at Fisher At the right price, this would be an interesting play on health care and biomedical research. Investors, take note. mark for My Articles similar articles
The Motley Fool
October 26, 2007
Brian Orelli
This Just In: Mergers Do Indeed Lower Costs As the anniversary integration between Thermo Electron and Fisher Scientific approaches next week, Thermo Fisher Scientific announced third-quarter results that demonstrated how the integration is having a nice effect on the bottom line. mark for My Articles similar articles
CIO
July 27, 2012
Kim S. Nash
How Thermo Fisher Mines Customer Feedback to Improve Service Thermo Fisher Scientific overhauled its customer feedback system to allow it to be more responsive to current customers and to take advantage of emerging markets mark for My Articles similar articles
The Motley Fool
October 26, 2011
Tim Beyers
Thermo Fisher Scientific Shares Plunged: What You Need to Know Shares of Thermo Fisher Scientific fell more than 10% in early trading and closed off almost that much after lowering full-year earnings and revenue guidance. mark for My Articles similar articles
The Motley Fool
April 20, 2006
Stephen D. Simpson
Will Danaher Break the Cycle? This diversified company seems to be moving toward less cyclical sensitivity. What does it mean for investors? mark for My Articles similar articles
The Motley Fool
August 16, 2007
Brian Orelli
More Drugmaker Growth Without the FDA All that high-tech lab equipment has to come from somewhere. Here's how investors can benefit from it, too. mark for My Articles similar articles
The Motley Fool
April 27, 2009
Toby Shute
The Industrial Elephant in the Room Danaher, the large conglomerate which makes everything from postal scanners to dental instruments, is far from a household name, but it is a name you should get to know. mark for My Articles similar articles
The Motley Fool
July 20, 2006
Stephen D. Simpson
More Blocking and Tackling From Danaher For those investors who lean toward quality over quantity, Danaher might be the ticket. mark for My Articles similar articles
Chemistry World
April 19, 2013
Sarah Houlton
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. mark for My Articles similar articles
BusinessWeek
January 22, 2007
Aaron Pressman
Homeland Security 2.0 Five years after September 11, a new wave of smarter high-tech tools is coming to market. mark for My Articles similar articles
The Motley Fool
June 2, 2006
Stephen D. Simpson
Pall Still Looks Clogged Weak margins and poor returns on capital don't make for a compelling case for this leading player in filtration and separation equipment and technology. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 16, 2005
Stephen D. Simpson
Clean Air for CLARCOR This business supplies all manner of filtration products for powered vehicles, though autos are not a major driver, and the slowdown in domestic auto sales isn't really hurting the business. But valuations are beginning to look a bit stretched, so investors need to tread carefully. mark for My Articles similar articles
The Motley Fool
October 10, 2011
Alex Dumortier
Don't Buy Into Pall's Share Buyback Purification and filtration products manufacturer Pall's new buyback program is no "buy" indicator. mark for My Articles similar articles
The Motley Fool
November 9, 2005
Stephen D. Simpson
Fishing for Value at Fisher Even with today's earnings-induced jump, there still might be some value here at researcher Fisher Scientific. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 21, 2005
Stephen D. Simpson
Oh, Danny Boy ... Danaher has a bewildering array of businesses, but they've delivered growth so far. Annualizing the second quarter's results leaves you with a return on assets of more than 10% and a return on equity of close to 20% -- two hallmarks of well-run companies. Investors, take note. mark for My Articles similar articles